BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10814223)

  • 1. An efficient, stereospecific synthesis of the dimer-selective retinoid X receptor modulator (2E,4E,6Z)-7-[5,6,7,8- tetrahydro-5,5, 8,8-tetramethyl-2-(n-propyloxy)naphthalen-3-yl]-3-methyl octa-2,4, 6-trienoic acid.
    Hamann LG
    J Org Chem; 2000 May; 65(10):3233-5. PubMed ID: 10814223
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational effects on retinoid receptor selectivity. 1. Effect of 9-double bond geometry on retinoid X receptor activity.
    Jong L; Lehmann JM; Hobbs PD; Harlev E; Huffman JC; Pfahl M; Dawson MI
    J Med Chem; 1993 Sep; 36(18):2605-13. PubMed ID: 8410972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity.
    Dawson MI; Jong L; Hobbs PD; Cameron JF; Chao WR; Pfahl M; Lee MO; Shroot B; Pfahl M
    J Med Chem; 1995 Aug; 38(17):3368-83. PubMed ID: 7650690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.
    Boehm MF; Zhang L; Zhi L; McClurg MR; Berger E; Wagoner M; Mais DE; Suto CM; Davies JA; Heyman RA
    J Med Chem; 1995 Aug; 38(16):3146-55. PubMed ID: 7636877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
    Vu-Dac N; Gervois P; Torra IP; Fruchart JC; Kosykh V; Kooistra T; Princen HM; Dallongeville J; Staels B
    J Clin Invest; 1998 Aug; 102(3):625-32. PubMed ID: 9691099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.
    Zhang L; Nadzan AM; Heyman RA; Love DL; Mais DE; Croston G; Lamph WW; Boehm MF
    J Med Chem; 1996 Jul; 39(14):2659-63. PubMed ID: 8709094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.
    Boehm MF; Zhang L; Badea BA; White SK; Mais DE; Berger E; Suto CM; Goldman ME; Heyman RA
    J Med Chem; 1994 Sep; 37(18):2930-41. PubMed ID: 8071941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
    Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel retinoid X receptor-selective retinoids.
    Faul MM; Ratz AM; Sullivan KA; Trankle WG; Winneroski LL
    J Org Chem; 2001 Aug; 66(17):5772-82. PubMed ID: 11511251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of apolipoprotein(a) synthesis in cynomolgus monkey hepatocytes by retinoids via involvement of the retinoic acid receptor.
    Neele DM; de Wit EC; Princen HM
    Biochem Pharmacol; 1999 Jul; 58(2):263-71. PubMed ID: 10423167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
    Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
    Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
    Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
    J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
    Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
    Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid (9cUAB30).
    Atigadda VR; Vines KK; Grubbs CJ; Hill DL; Beenken SL; Bland KI; Brouillette WJ; Muccio DD
    J Med Chem; 2003 Aug; 46(17):3766-9. PubMed ID: 12904083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of retinoid X receptor transcriptional antagonism.
    Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
    J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
    Lotan R; Dawson MI; Zou CC; Jong L; Lotan D; Zou CP
    Cancer Res; 1995 Jan; 55(2):232-6. PubMed ID: 7812950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
    Tian K; Norris AW; Lin CL; Li E
    Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of specific RXR heterodimers by an antagonist of RXR homodimers.
    Lala DS; Mukherjee R; Schulman IG; Koch SS; Dardashti LJ; Nadzan AM; Croston GE; Evans RM; Heyman RA
    Nature; 1996 Oct; 383(6599):450-3. PubMed ID: 8837780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
    Desphande A; Xia G; Boerma LJ; Vines KK; Atigadda VR; Lobo-Ruppert S; Grubbs CJ; Moeinpour FL; Smith CD; Christov K; Brouillette WJ; Muccio DD
    Bioorg Med Chem; 2014 Jan; 22(1):178-85. PubMed ID: 24359708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.